The researchers added that these expression changes could be used to predict when a bloom might occur.
The single-cell approach enabled them to identify gene expression in rare cell types, highlighting a previously unrecognized role for these cells in diabetes.
Babraham Institute researchers used promoter capture Hi-C to determine the interactomes of 31,000 promoters in blood cells.
The company recently urged shareholders to approve the deal, saying the cash consideration they'd receive would represent a premium over recent stock prices.
Merck is hoping NanoString's multiplex platform can support gene expression signatures that will better predict which patients will respond to checkpoint inhibitors like its Keytruda.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.